Evidence map›Paper›PMID 30019387›Full record

ArticleCancer medicine2018

Financial burden among older, long-term cancer survivors: Results from the LILAC study.

Theresa A Hastert, Gregory S Young, Michael L Pennell, Tasleem Padamsee, S Yousuf Zafar, Cecilia DeGraffinreid, Michelle Naughton, Michael Simon, Electra D Paskett

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
8.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Financial Hardship by Age at Diagnosis Including in Young Adulthood among African American Cancer Survivors.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  10. Article
  11. Article
  12. The relationships of unmet needs with quality of life and characteristics of Indonesian gynecologic cancer survivors.Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2021
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2019
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Theresa A HastertDepartment of Oncology, Wayne State University School of Medicine, Detroit, Michigan.ORCID 0000-0001-6251-6422
Gregory S YoungDepartment of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, Ohio.ORCID 0000-0001-9886-6205
Michael L PennellDivision of Biostatistics, College of Public Health, The Ohio State University, Columbus, Ohio.
Tasleem PadamseeDivision of Health Services Management & Policy, College of Public Health, The Ohio State University, Columbus, Ohio.ORCID 0000-0001-6644-8084
S Yousuf ZafarDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina.ORCID 0000-0002-9039-5258
Cecilia DeGraffinreidThe James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Michelle NaughtonThe James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Michael SimonDepartment of Oncology, Wayne State University School of Medicine, Detroit, Michigan.ORCID 0000-0002-3237-6761
Electra D PaskettDivision of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio.ORCID 0000-0002-8247-8299
The Ohio State University · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USWayne State University · USPublic Policy Institute of California · US

Funding

Women's Health Initiative Cancer Survivor CohortUM1CA173642 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ANDERSON, GARNET L., CAAN, BETTE J · 2013 to 2018
$12.1M
Life and Longevity After Cancer (LILAC): The Women's Health Initiative Cancer Survivor CohortU01CA173642 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ANDERSON, GARNET L., PASKETT, ELECTRA D. · 2019 to 2023
$7.5M
NCI NIH HHS U01 CA173642NCI NIH HHS UM1 CA173642NHLBI NIH HHS HHSN268201600001CNHLBI NIH HHS HHSN268201600002CNHLBI NIH HHS HHSN268201600003CNHLBI NIH HHS HHSN268201600004CNHLBI NIH HHS HHSN268201600018C
6 · The paper itself

Abstract

backgroundIncreasing attention is being paid to financial burdens of cancer survivorship, but little is known about the prevalence and predictors of these burdens in older, long-term survivors.

methodsWe used data from 6012 participants diagnosed with cancer since enrolling in the Women's Health Initiative, and who participated in the Life and Longevity After Cancer (LILAC) ancillary study to estimate prevalence and identify predictors of financial burden. We used logistic regression to identify sociodemographic, socioeconomic, health- and cancer-related factors associated with financial burden and backward selection to build a final multivariable model.

resultsAverage age at LILAC participation was 79 and 9.2 years had elapsed since cancer diagnosis. Overall, 6% experienced some form of financial burden, including having an insurance company refuse a claim (2.6%), being denied loans or insurance due to cancer history (2.2%), or experiencing significant indebtedness (1.8%, including facing large debts or bills or declaring bankruptcy). Eight predictors remained associated (P < 0.05) with financial burden in the fully-adjusted model: younger age, shorter time since diagnosis, African-American race, household income <$20 000/year, modified Charlson comorbidity score ≥2, receipt of chemotherapy, regional stage at diagnosis, and no private health insurance. Education, cancer site, social support, receipt of radiation, and receipt of hormone therapy were not associated with financial burden. Predictors differed between types of financial burden experienced and age at diagnosis (<65 vs 65+).

conclusionCancer-related financial burden was rare in this population of older, female long-term cancer survivors. The identification of several socioeconomic, health-related and demographic predictors of financial burden may suggest targets of intervention to reduce financial burdens. PRECIS: Financial burden was uncommon in older, female, long-term survivors. Predictors of financial burden included age, race, income, comorbidities, time since diagnosis, stage, insurance, and receipt of chemotherapy.

Indexed as

Cancer SurvivorsCost of IllnessHealth ExpendituresAgedAged, 80 and overFemaleHumansMaleNeoplasmsOdds RatioPublic Health SurveillanceQuality of LifeSocioeconomic FactorsSurveys and QuestionnairesSurvivorscancercancer economicscancer therapyfinancial hardshipsurvivorship

Identifiers

PMID30019387
PMCPMC6143934
OpenAlexW2884143484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.